Expression of C‐erbB‐2 oncoprotein in gastric carcinoma. Immunoreactivity for C‐erbB‐2 protein is an independent indicator of poor short‐term prognosis in patients with gastric carcinoma

Cancer

Volumn 67, Issue 11, 1991, Pages 2914-2918

  Yonemura, Yutaka ^a   Ninomiya, Itasu ^a   Ohoyama, Shigekazu ^a   Kimura, Hironobu ^a   Yamaguchi, Akio ^a   Fushida, Sachio ^a   Miyazaki, Ituo ^a   Endou, Yoshio ^a   Tanaka, Motohiro ^a   Sasaki, Takuma ^a   Kosaka, Takeo ^b   Miwa, Kouichi ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA;

ADULT; AGED; FEMALE; GENE AMPLIFICATION; HUMAN; MALE; MIDDLE AGE; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR, ERBB-2; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0025881623     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19910601)67:11<2914::AID-CNCR2820671134>3.0.CO;2-G     Document Type: Article

References (27)

1. Lymph node metastases of gastric cancer
2. The general rules for the gastric cancer study and an analysis of treatment results based on the rules
3. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S‐phase fraction in gastric carcinoma
4. Amplification and expression of a cellular oncogene (c‐ myc) in human gastric adenocarcinoma cells
5. Expression of ras oncogene p21 in early gastric carcinoma and adjacent gastric epithelia
6. Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma
7. Enhanced expression of c‐Ha‐ ras p21 in human stomach adenocarcinomas defined by immunoassay using monoclonal antibody and in situ hybridization
8. Immunohistochemical detection of c‐ myc oncogene product in human gastric carcinomas: Expression in tumor cells and stromal cells
9. Epidermal growth factor receptor status and S‐phase fractions in gastric carcinoma
10. The neu oncogene encodes an epidermal growth factor receptor‐related protein
11. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
12. Sporadic amplification of the HER2/ neu protooncogene in adenocarcinomas of various tissues
13. Amplification, overexpression and rearrangement of the erbB‐2 protooncogene in primary human stomach carcinomas
14. Human breast cancer: Correlation of relapse and survival with amplification of the HER‐2/neu oncogene
15. Correlation of c‐erbB‐2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading
16. Regression model and life tables
17. The general rules for the gastric cancer study in surgery and pathology: Part I
18. Immunohistochemical localization of c‐erbB‐2 in human breast carcinomas
19. Neu3‐protein overexpression in breast cancer: Association with comedo‐type ductal carcinoma in situ and limited prognostic value in Stage II breast cancer
20. Expression of c‐erbB‐2 oncoprotein: A prognostic indicator in human breast cancer
21. c‐erbB‐2 oncogene product staining in gastric adenocarcinoma: An immunohistochemical study
22. An evaluation of immunoreactivity for c‐erbB‐2 protein as a marker of poor short‐term prognosis in breast cancer
23. Alterrations to either c‐erbB‐2 (neu) or c‐myc proto‐oncogenes in breast carcinomas correlated with poor short‐term prognosis
24. An immunohistochemical evaluation of c‐erbB‐2 expression in human breast carcinoma
25. A Mr 190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor receptor stimulated KB cells in the product of c‐erbB‐2 gene
26. Studies on a new epidermal growth factor‐receptor kinase inhibitor, erbstatin, produced by MH435‐hF3
27. Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene‐encoded tumor antigen